THE unsatisfactory state of our knowledge regarding the effect of cortisone on capillary permeability has been discussed in a previous paper (Duke-Elder and Ashton, 1951) . It was there noted that Leopold and others (1951), injecting fluorescein intravenously in rabbits and estimating its concentration in the aqueous humour, observed no delay in the appearance of the dye in the anterior chambers of cortisone-treated animals in comparison with normal controls. From this it may be concluded that cortisone has no effect on the permeability of the capillaries in the normal eye, for molecules of the size of fluorescein. We have confirmed these negative findings by the use of the same method with a slightly modified technique. In our experiments an intravenous injection of 0.05 ml. 10 per cent. fluorescein was given, and cortisone was injected both intramuscularly (0.5 ml. of 25 mg./ml. solution) and subconjunctivally (0.25 ml. of 25 mg./ml. solution).
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We have extended their investigations to explore the effect of cortisone on the capillary permeability in human eyes in which inflammatory manifestations were present and also in those in which it was absent. Method A series of ten cases, comprising a variety of ocular inflammatory conditions, was treated with cortisone. In each case a capillary permeability test was done both before and during cortisone therapy, and in six cases a further test was carried out after cessation of cortisone treatment at periods varying from 2 to 9 weeks. The relative concentrations of fluorescein entering the anterior chamber were estimated and recorded on the Amsler-Huber Chart. A fluorescein permeability curve for both eyes was thus obtained on each occasion.
CORTISONE AND PERMEABILITY recorded. Comparison of the resulting curves may, therefore, be mjsleading. However, a conversion curve has been calculated experimentally, by means of which these readings may be converted from amperes to absolute concentrations of fluorescein (Fig. 1) November, 1950 . ln January, 1951, a course of subconjunctival cortisone injections was given. There was a marked response and the condition became inactive within 4 weeks. After 14 weeks a relapse occurred.
Conditioni before Treatmient.-The right eye was injected. There was a diffuse corneal haze, scattered keratic precipitates, and a mild aqueous flare. Vision was reduced from 6/9 to 6/24.
Treatment.---10 mg. subconjunctival cortisone twice weekly.
Course. There was a good response and the keratitis became inactive in 17 days. Capillary permeability tests were carried out before, during, and after treatment of the relapse. Case 7, A. C., aged 51 years. Diagnosis. Recurrent non-specific deep keratitis of the right eye. Condition before Treatmnent. The eye was moderately injected and very photophobic. A dense corneal infiltrate with a surrounding zone of faint corneal haze was present, and therc was a faint aqueous flare.
Treatment. Subconjunctival injection of 10 mg. cortisone at intervals of 4 days. Coarse. There was a marked improvement within 4 days and in 11 days the eye was white and quiet leaving a residual peripheral scar. Case 8, L. W., aged 56 years.
Diagnosi.s. Recurrent bilateral rosacea keratitis of 9 years' duration.
RIGHT EYE
Condition before Treatment.-The eye was mildly injected and slightly photophobic. The cornea showed bilateral scarring with superficial vascularization but there was no corneal staining.
Treatment. Cortisone drops instilled hourly.
Course.-The eye was white and quiet in 7 days.
LEFT EYE Condition before Treatment. The eye was mildly injected and very photophobic.
The cornea showed diffuse corneal scarring with superficial vascularization and a small area of corneal staining was present temporally.
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Course.-There was a marked improvement and the eye was white and quiet in 2 weeks. Case 9, J. B., aged 43 years. Diagnosis.-Bilateral perivasculitis retinae of 3 years' duration. Condition before Treatment.-Right eye was white and the anterior chamber was clear but there was a dense vitreous haze which obscured the fundus. The left eye showed a dense aqueous flare and heavy vitreous haze was present which obscured the fundus.
Treatment.-10 mg. cortisone subconjunctivally to both eyes twice weekly. Course.-There was a slow but progressive clearing of both eyes. The aqueous flare in the left eye disappeared within two weeks and the vision had improved to 6/18 in both eyes in 2 months.
Case 10, ¶1D. D., aged 26 years.
Diagnosis.-Bilateral rosacea keratitis of 3 years' duration. RIGHT EYE Condition before Treatment.-The eye was much injected and very photophobic. The cornea showed dense peripheral scarring with superficial vascularization, and a large staining area was present at the nasal periphery. The anterior chamber showed no cells or flare.
Treatment.-10 mg. cortisone subconjunctivally twice weekly.
Course.-The eye showed a definite symptomatic improvement and became white in 8 days, but there has so far been no change in the staining area.
LEFr EYE
Condition before Treatment.-The eye showed mild injection with slight photophobia. Dense peripheral scarring with superficial vascularization was present in the cornea and there were scattered punctate areas of staining at the lower periphery. The anterior chamber showed no cells or flare.
Treatment.-Cortisone drops given hourly. Course.-The eye became white and quiet within 7 days but the punctate areas of staining were and are still present.
Discussion
The results obtained from the individual capillary permeability curves are summarized in the Table (overleaf). The permeability curves of Case 7, treated with subconjunctival cortisone, are typical examples (Fig. 2a, b, c) . Fig. 3a , b, c shows the same curves with the ampere readings converted into absolute readings of fluorescein. Further examples are shown in Fig. 4a , b, c (Case 1, treated with systemic cortisone), and in Fig. 5a , b, c (Case 8, right eye treated by cortisone drops, left eye by subconjunctival injections and drops).
It will be observed that in ten of the thirteen eyes showing clinical evidence of inflammation the relative concentrations of fluorescein in the aqueous were lowered. Of the three eyes showing no change, there was a marked delay in the entrance of fluorescein into the anterior chamber of one, and the inflammatory manifestations in the remaining two were confined to the fundus, the anterior segment showing no evidence of involvement. In Case 5, which showed only degenerative choroidal changes, there was also no change in capillary permeability. It is noteworthy that cortisone therapy influenced the capillary permeability in none of the five eyes showing no evidence Of. capillary wall. The permeability curves recorded in six cases after the withdrawal of cortisone show, however, that the capillary permeability tends to increase after treatment has been discontinued, although in each patient the ocular condition was clinically quiescent. This would appear to indicate that the preliminary fall in permeability obtained during treatment may be independent of the associated inflammatory manifestations. The possibility of the persistence of a residual sub-clinical inflammatory reaction cannot, however, be completely excluded. The existence of this possibility is demonstrated by Case 6, in which a relapse occurred after the withdrawal of cortisone, the basic inflammatory diathesis having presumably been uninfluenced.
Conclusions
The results obtained in these investigations indicate that the capillary permeability in the normal human eye is not influenced by cortisone. It would appear, however, that cortisone, given either locally or systemically, plays an important role in the reduction of the increase of capillary permeability associated with inflammation. The permeability curves taken after the withdrawal of cortisone suggest that the decrease in permeability does not vary directly with inflammatory activity. This may be regarded as presumptive evidence that cortisone has a direct action on the capillaries, although the possibility cannot be excluded that the rapid increase of permeability found after cortisone treatment had ceased, and in the absence of clinically apparent evidences of inflammation may be due to a persistence of the basic factor or factors determining the pathological condition. 
